This trial is testing if providing enhanced symptom management and remote monitoring to patients undergoing chemotherapy can help reduce the number of emergency room visits and hospitalizations.
1 Primary · 3 Secondary · Reporting Duration: Baseline to 6 months
Active Control
Experimental Treatment
600 Total Participants · 2 Treatment Groups
Primary Treatment: Patient Monitoring · No Placebo Group · N/A
Age 18+ · All Participants · 4 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you: